Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

2 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Perception of the impact of intravenous biological treatment on the work and professional environment in patients with inflammatory bowel disease.
González-Muñoza C, Gely C, Gordillo J, Calafat M, Bertoletti F, Cañete F, Mañosa M, López-Faba A, Torres P, Domènech E, Garcia-Planella E. González-Muñoza C, et al. Among authors: lopez faba a. Gastroenterol Hepatol. 2024 Dec;47(10):502193. doi: 10.1016/j.gastrohep.2024.502193. Epub 2024 May 7. Gastroenterol Hepatol. 2024. PMID: 38723767 English, Spanish.
Duration of smoking cessation in patients with inflammatory bowel disease.
González-Muñoza C, Gely C, Gordillo J, Bertoletti F, Giordano A, López-Faba A, García-Planella E. González-Muñoza C, et al. Among authors: lopez faba a. Gastroenterol Hepatol. 2024 Jun-Jul;47(6):591-597. doi: 10.1016/j.gastrohep.2023.11.002. Epub 2023 Nov 15. Gastroenterol Hepatol. 2024. PMID: 37977427 English, Spanish.